investigated the effect of RNF43 deletion mutations on colon cancer progression and showed that knockdown of RNF43 using the CRISPR/Cas9 system activated Wnt signaling, accelerated tumor growth, and increased recurrence rates in patients with colon cancer (39). The gene discussed is RNF43; the disease is colonic neoplasm.